☆ 4.6 Article

Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study

ANESTHESIOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Critical Care Medicine

Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU

Christina Creel-Bulos et al.

Summary: The COVID-19 pandemic has led to serious complications including systemic inflammation, organ dysfunction, and thromboembolic disease. Within the institution, a study on critically ill patients found a high prevalence of fibrinolysis shutdown among those who experienced thrombotic events. This suggests the potential benefit of using viscoelastic testing to identify patients who may benefit from fibrinolytic therapy.

SHOCK (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Rotational thromboelastometry results are associated with care level in COVID-19

Lou M. Almskog et al.

Summary: High prevalence of thrombotic events in severely ill COVID-19 patients has been reported, with hypercoagulopathy being present early in patients with mild to moderate disease and more pronounced in severe cases. ROTEM variables at admission show hypercoagulopathy, more prominent in patients with increased disease severity, suggesting that further studies are needed to predict the risk of thromboembolic complications.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Add to Collection

Article Anesthesiology

Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients

Christoph Heinz et al.

Summary: The study found significant changes in clot formation and lysis in COVID-19 patients, particularly in increased fibrin contribution to maximum clot firmness and prolongation of lysis time. These findings may contribute to our understanding of the hypercoagulable state in critically ill patients with COVID-19.

ANESTHESIOLOGY (2021)

Add to Collection

Article Peripheral Vascular Disease

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

Aurelien Philippe et al.

Summary: This study examined the correlation between endothelial dysfunction and in-hospital mortality in COVID-19 patients. Results showed that levels of various endothelial biomarkers were elevated in critically ill patients, particularly Von Willebrand factor antigen (VWF:Ag) and high molecular weight multimers (HMWM). VWF:Ag was identified as the best predictor for in-hospital mortality among all endothelial biomarkers measured.

ANGIOGENESIS (2021)

Add to Collection

Review Biochemical Research Methods

Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death

Wenjing Chen et al.

Summary: COVID-19 patients mainly die from DAD and DIC, with microthrombosis being a prominent clinical feature leading to microcirculation disorders and organ failure.

BIOLOGICAL PROCEDURES ONLINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19 Results From the American Heart Association COVID-19 Cardiovascular Disease Registry

Nicholas S. Hendren et al.

Summary: This study found that obese patients are more likely to be hospitalized with COVID-19, and are at higher risk of in-hospital death or mechanical ventilation, particularly if young (age <= 50 years). Additionally, obese patients are also at higher risk for venous thromboembolism and dialysis. These observations support clear public health messaging and rigorous adherence to COVID-19 prevention strategies in all obese individuals regardless of age.

CIRCULATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

Yu Zuo et al.

Summary: COVID-19 patients have elevated levels of tPA and PAI-1 in plasma, which are correlated with neutrophil counts and respiratory status. Particularly high levels of tPA are strongly associated with mortality and enhanced fibrinolysis, suggesting a subset of patients may have a favorable balance of factors for fibrinolysis. Further investigation into tPA as a biomarker is warranted.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Critical Care Medicine

d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019

Samuel A. P. Short et al.

Summary: In critically ill patients with severe coronavirus disease 2019, higher levels of d-dimer were independently associated with a greater risk of death, even after multivariable adjustment. Therapeutic anticoagulation did not significantly affect this relationship.

CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019

Adrian A. N. Doevelaar et al.

Summary: The study suggests that COVID-19 patients have significantly increased levels of von Willebrand factor, potentially leading to a relative deficiency of ADAMTS13 and the formation of large von Willebrand factor multimers, similar to thrombotic thrombocytopenic purpura. The ADAMTS13/von Willebrand factor antigen ratio is an independent predictor of disease severity and mortality, highlighting the potential use of plasma exchange as a therapeutic option and the inclusion of these factors in diagnostic workup for COVID-19.

CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Cell Biology

Rotational Thromboelastometry (ROTEM) Profiling of COVID-19 Patients

Mirjana Mitrovic et al.

Summary: The study evaluated coagulation abnormalities in 94 patients with COVID-19 of varying severity, finding a higher frequency of hypercoagulable state in patients with advanced disease and high IL6 levels. Therefore, different thromboprophylaxis approaches are needed for patients with different severity levels.

PLATELETS (2021)

Add to Collection

Article Hematology

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Adam Cuker et al.

Summary: The American Society of Hematology provided two conditional recommendations for anticoagulation in COVID-19-related critical illness and acute illness, emphasizing the low certainty in the evidence and the importance of future high-quality randomized controlled trials for validation.

BLOOD ADVANCES (2021)

Add to Collection

Article Hematology

Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients

Kristina Boss et al.

Summary: The ROTEM analysis revealed significantly different pathological findings characterized by hypercoagulability and fibrinolysis shutdown among COVID-19 patients with a severe disease course compared to patients with severe sepsis, indicating a higher risk of thromboembolic events in COVID-19 patients.

THROMBOSIS JOURNAL (2021)

Add to Collection

Article Hematology

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study

Ganeem K. Juneja et al.

Summary: Immunothrombosis and coagulopathy in the lung microvasculature may lead to lung injury and disease progression in COVID-19. Biomarkers such as elevated D-dimer were associated with disease severity, while clot lysis time, sTM, PAI-1, and plasminogen levels may have predictive ability for mortality.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Review Multidisciplinary Sciences

A systematic review and meta-analysis of obesity and COVID-19 outcomes

Xinya Zhang et al.

Summary: Studies suggest that obesity is associated with more severe COVID-19 symptoms and outcomes, with obese patients more likely to develop severe symptoms and require hospitalization or intensive care, but they have similar mortality rates compared to non-obese patients.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Endocrinology & Metabolism

Obesity andCOVID-19: A jigsaw puzzle with still missing pieces

Konstantinos Michalakis et al.

Summary: Obesity not only poses various health issues but also increases susceptibility to respiratory infections and has considerable impact on COVID-19 morbidity and mortality. Understanding the potential pathophysiological pathways linking obesity and COVID-19 could help explain why obese patients are more prone to respiratory infections and guide future management strategies.

CLINICAL OBESITY (2021)

Add to Collection

Article Hematology

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Medical Laboratory Technology

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Cynthia Magro et al.

TRANSLATIONAL RESEARCH (2020)

Add to Collection

Article Surgery

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection

Franklin L. Wright et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Add to Collection

Article Hematology

Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series

Janice Wang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Editorial Material Hematology

Thromboinflammation and the hypercoagulability of COVID-19

Jean M. Connors et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Litao Zhang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Letter Hematology

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Marisa Dolhnikoff et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations

Brijesh Patel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Severe COVID-19 Is a Microvascular Disease

Charles J. Lowenstein et al.

CIRCULATION (2020)

Add to Collection

News Item Multidisciplinary Sciences

Blood vessel injury may spur disease's fatal second phase

Catherine Matacic

SCIENCE (2020)

Add to Collection

Review Hematology

Thrombosis risk associated with COVID-19 infection. A scoping review

Fatimah Al-Ani et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Review Cell Biology

The coagulopathy, endotheliopathy, and vasculitis of COVID-19

Toshiaki Iba et al.

INFLAMMATION RESEARCH (2020)

Add to Collection

Article Hematology

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)

Anna Cristina Bertoldi Lemos et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Critical Care Medicine

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Jan Matthias Kruse et al.

CRITICAL CARE (2020)

Add to Collection

Review Medicine, General & Internal

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Mahmoud B. Malas et al.

ECLINICALMEDICINE (2020)

Add to Collection

Article Critical Care Medicine

War to the knife against thromboinflammation to protect endothelial function of COVID-19 patients

Gabriele Guglielmetti et al.

CRITICAL CARE (2020)

Add to Collection

Review Critical Care Medicine

The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology

Jonathan E. Millar et al.

CRITICAL CARE (2016)

Add to Collection

Review Anesthesiology

Extracorporeal Membrane Oxygenation in the Adult: A Review of Anticoagulation Monitoring and Transfusion

Stephen A. Esper et al.

ANESTHESIA AND ANALGESIA (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of PAI-1 Antiproteolytic Activity Against tPA by RNA Aptamers

Jared Damare et al.

NUCLEIC ACID THERAPEUTICS (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

The many faces of the contact pathway and their role in thrombosis

Rebecca S. Woodruff et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Antimetastatic Potential of PAI-1-Specific RNA Aptamers

Charlene M. Blake et al.

OLIGONUCLEOTIDES (2009)

Add to Collection

Review Hematology

PAI-1 and the metabolic syndrome - Links, causes, and consequences

Marie-Christine Alessi et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Add to Collection

Article Hematology

ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences

HB Feys et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Add to Collection

Article Hematology

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

A Dahm et al.

BLOOD (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.